ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979

NCI CTEP-Approved Trials For the Month of June

June 27, 2014

Group Sets Prostate Research Agenda; Strategy, Funding Demands to Follow

November 8, 1996

Strategic Plan Identifies Goal; To Be The Authoritative Source For Cancer Information

May 21, 1999

FDA To Issue “Complete Response” Letters To Drug Sponsors.

July 11, 2008

Obama’s First Budget Proposes $6 Billion For Cancer Research As Step To Doubling

February 27, 2009